Intern, Infectious Disease Epidemiology
Moderna
Summary
This is a full-time summer internship based in Cambridge, MA from June 7, 2027 – August 20, 2027. Candidates must be available for the entire duration of the program. We are seeking a highly motivated PhD/ScD student to join our Infectious Disease Epidemiology team, providing a unique opportunity to gain hands-on experience in real-world epidemiologic research, vaccine development, and decision-making processes to support vaccine development programs for Moderna's portfolio of vaccines for infectious respiratory viruses (influenza, RSV, SARS-CoV-2), gastrointestinal viruses (norovirus), and others.
Job description
The Role
This is a full-time summer internship based in Cambridge, MA from June 7, 2027 – August 20, 2027. Candidates must be available for the entire duration of the program. We are seeking a highly motivated PhD/ScD student to join our Infectious Disease Epidemiology team, providing a unique opportunity to gain hands-on experience in real-world epidemiologic research, vaccine development, and decision-making processes to support vaccine development programs for Moderna's portfolio of vaccines for infectious respiratory viruses (influenza, RSV, SARS-CoV-2), gastrointestinal viruses (norovirus), and others.
Here's What You'll Do
- Gain exposure to the role of Epidemiology in vaccine development, supporting clinical trial conduct and post-marketing observational research
- Lead and execute epidemiologic analyses on disease burden of infectious diseases and related health outcomes, including study design, data analysis, and interpretation of results
- Communicate findings effectively through data visualization, reports, and presentations to cross-functional teams and leadership
- Engage with cross-functional teams, including Clinical Development, Medical Affairs, Health Economics & Outcomes Research (HEOR), and Real-World Evidence Analytics
- Contribute to regular cross-functional discussions on evidence generation strategies for infectious disease programs, shaping research priorities and decision-making
Here's What You'll Need (Minimum Qualifications)
- Currently enrolled in a PhD or ScD program in Epidemiology or a closely related discipline
- Strong background in epidemiology, biostatistics
- Experience with SAS, R, STATA, or similar is a plus
Here's What You'll Bring to the Table (Preferred Qualifications)
- Interest in vaccine development, pharmacoepidemiologic methods, pharmacovigilance, and data-driven decision-making
- Ability to meet deadlines, team-oriented mindset, adaptability under pressure, and a proactive approach to problem-solving
- Demonstrated ability to work independently while contributing effectively within a team environment
- Strong written and verbal communication skills
- High attention to detail and commitment to quality and compliance
Requirements
- Currently enrolled in a PhD or ScD program in Epidemiology or a closely related discipline
- Strong background in epidemiology
- Strong background in biostatistics
- Experience with SAS, R, STATA, or similar is a plus
- Interest in vaccine development, pharmacoepidemiologic methods, pharmacovigilance, and data-driven decision-making
- Ability to meet deadlines, team-oriented mindset, adaptability under pressure, and a proactive approach to problem-solving
- Demonstrated ability to work independently while contributing effectively within a team environment
- Strong written and verbal communication skills
- High attention to detail and commitment to quality and compliance
Benefits
- Meditation and mindfulness classes
- Subsidized commuter benefits
- Paid time off
- Vacation
- Sick time
- Holidays
- Volunteer days
- Discretionary year-end shutdown
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.